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Abstract
Healthy aging and longevity in humans are modulated by a lucky combination of genetic and non-genetic factors.
Family studies demonstrated that about 25 % of the variation in human longevity is due to genetic factors. The
search for genetic and molecular basis of aging has led to the identification of genes correlated with the
maintenance of the cell and of its basic metabolism as the main genetic factors affecting the individual variation of
the aging phenotype. In addition, studies on calorie restriction and on the variability of genes associated with
nutrient-sensing signaling, have shown that ipocaloric diet and/or a genetically efficient metabolism of nutrients,
can modulate lifespan by promoting an efficient maintenance of the cell and of the organism. Recently, epigenetic
studies have shown that epigenetic modifications, modulated by both genetic background and lifestyle, are very
sensitive to the aging process and can either be a biomarker of the quality of aging or influence the rate and the
quality of aging.
On the whole, current studies are showing that interventions modulating the interaction between genetic
background and environment is essential to determine the individual chance to attain longevity.
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Background
The research on aging, and in particular the search for
the determinants of successful aging and longevity, has
been continuously growing in the last decades also due
to the social and medical burden correlated to the con-
tinuous increase of lifespan in western countries and the
consequent grow of the elderly population. One of the
main questions in this field is the correlation between
the genetic background and lifestyle in determining the
individual chance of a delayed aging (possibly without
age-related diseases and disabilities) and longevity. The
results obtained by biogerontologists in these years,
which highlighted most of the biological and biochem-
ical mechanisms involved in the aging process, allowed
to better understand such correlation. This has brought
to elaborate important strategies focused on possible
interventions to improve lifestyle in order to increase
the chance to attain longevity by modulating the basic
molecular mechanisms of aging.
The genetics of aging
Before the 1990ies it was largely spread the idea that
aging is ineluctable and that genetics does not control it.
It was important, in this view, the idea that aging occurs
after reproduction, and then there is no need, but also
no opportunity, for selection to act on genes that are
expressed during this late period of life [1].
The researcher who pioneered the genetics of aging and
longevity was Tom Johnson, who studied groups of C.
elegans where he was able to separate long living individ-
uals from short living subjects. The analysis of hybrids
obtained from different strains of C. elegans, allowed to es-
timate that the heritability of life-span was between 20 and
50 % [2, 3]. Subsequently, he started the analysis of different
mutants and, with M. Klass, found a number of mutants
with longer lifespan. Subsequently, Tom Johnson found out
that most of the mutants with long lifespan had mutations
in the age1 gene [4]. This gene turned out to be the cata-
lytic subunit of class-I phosphatidylinositol 3-kinase (PI3K).
The studies of Johnson clearly demonstrated that gen-
etic variability could indeed affect lifespan. This trig-
gered many studies in model organisms in order to
disentangle the different biochemical pathways which
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could affect lifespan, and to highlight the genes coding
for the proteins involved in such pathways. In particular,
yeast, C. elegans, drosophila and mice were analyzed and
this highlighted numerous genes which could affect life-
span if mutated (for an updated list of these genes see
http://genomics.senescence.info/genes/models.html).
Most of these genes are related to the maintenance of
the integrity of the cell (especially the integrity of DNA).
In C. elegans, however, some of the main genes which
have been found to modulate lifespan (daf2, daf16) are
related to the ability to enter the dauer status [5, 6], that
is a quiescent status (usually entered in case of nutrient
deprivation) with a minimum energy expense, which
causes an arrest of the reproduction process and allows
the organism to live longer “expecting” for the availabil-
ity of nutrients. This suggested that longevity can be
attained by means of an efficient maintenance of the cell
but also by diverting resources from reproduction to self
maintenance, in line with previous findings that dietary
restriction can extend lifespan. After the characterization
of these genes in C. elegans, it was found that in mice
the ortholog of daf16 (FOXO) could affect lifespan. In
mammals, FOXO is correlated to the Insulin/IGF1 axis
which is stimulated by nutrient availability and, through
FOXO, promotes protein synthesis [7–11].
It is of note that some Authors suggested these molecular
mechanisms modulating lifespan could be due to a pleio-
tropic effect of genes which have evolved for different pur-
poses (such as the genes in the IGF-1 pathway which have
evolved to face presence/absence of nutrients) but can, ul-
timately affect lifespan; others proposed that some genes
may have evolved to program aging and avoid “immortal-
ity”, as this would hamper the continuous substitution of
old subjects with new, younger, ones [12, 13].
It was obviously inevitable that the research of the
genetic basis of longevity turned to human beings and
investigated whether the common genetic variability of
human populations could affect inter individual differ-
ences in lifespan but also whether the genes found to
prolong lifespan in model organisms, on turn, were cor-
related to human lifespan.
As to the first question (does common genetic vari-
ability affect lifespan, and in particular does it affect lon-
gevity?), this has been studied by two approaches. The
first one was the reconstruction of the sibships of long-
lived subjects [14, 15] and the comparison of their survival
curves with those of the birth cohorts born in the same
geographical area. This approach demonstrated that
brothers and sisters of the long-lived subjects had a clear
survival advantage (at any age) with respect to the general
population. The second approach, with intrafamily con-
trols, was started in order to distinguish the genetic from
the “familiar” effect. Montesanto et al. [15] compared the
survival function of brothers of centenarians with those
estimated for their brothers in law, that is with the men
who married their sisters; these men were supposed to
share with the brothers of the long lived subjects the fa-
miliar environment. By using this second approach, it has
been found that the survival advantage of siblings of long-
lived subjects was not completely shared by their brothers
in law, despite they shared the same environment for most
of their life. This suggested that beyond the family envir-
onment, there are genetic factors influencing survival and,
consequently, lifespan. Interestingly, in this study, the sur-
vival curve of the sisters of long-lived subjects did not dif-
fer from the one of sisters in law, suggesting that the
genetic component does explain lifespan in men more
than in women. The genetic component of lifespan in
humans has also been analyzed by comparing the age of
death of monozygotic and dizygotic twins. This has
allowed to estimate that about 25 % of the variation in
human longevity can be due to genetic factors and indi-
cated that this component is higher at older ages and is
more important in males than in females [16–18].
In parallel to these studies, many researches have been
carried out to search the genetic variants responsible of
modulating human longevity. Most of them were carried
out by a case/control approach, by comparing the fre-
quency of specific polymorphisms in long-lived subjects
and in younger geographically matched controls. The ra-
tionale of this study design is that as the population
ages, alleles favorable for survival will be present at
higher frequency among long-living people, while
unfavorable alleles will be eliminated [19–21]. The can-
didate genes analyzed by this approach were either genes
involved in age-related diseases (such as APOE, which
had been observed to be involved in the predisposition
to Alzheimer Disease and other age-related cognitive im-
pairments), or genes implicated in pathways related to
longevity in studies with model organisms (IGF-1,
FOXO, Sirtuins) [22–25]. This study design has indeed
led to find numerous polymorphic genes the variability
of which affects longevity. However, each of these poly-
morphisms turned out to explain only a very small frac-
tion of the longevity variability. Indeed high-throughput
Genome-wide analyses, which have recently been carried
out have identified many genes positively associated with
longevity but only a very few ones could hold multiple
test significance and successfully replicated in different
studies and across different populations [26–29]. Popu-
lation stratification and inadequate sample sizes are
among the main plausible explanations [30]. The
adoption of innovative study design and the develop-
ment of new statistical and computational tools for ef-
fective processing of genetic data arising from high-
throughput DNA technologies will help to better under-
stand the complex genetic architecture underlying
human longevity [31, 32].
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A new way of looking at the genetic data has been
proposed by Raule et al. [33] who analyzed the complete
sequences of mitochondrial DNA from long-lived sub-
jects coming from different areas of Europe. The avail-
ability of complete sequences allowed to evaluate for the
first time the cumulative effects of specific, concomitant
mitochondrial DNA (mtDNA) mutations, including
those that per se have a low, or very low, impact. The
analysis indicated that the presence of single mutations
on mtDNA complex I may be beneficial for longevity,
while the co-occurrence of mutations on both com-
plexes I and III or on both I and V might lower the indi-
vidual’s chances for longevity. Previous analyses on
single mutations falling on complex I (either specific
mutations or mutations defining groups of haplotypes)
had given contrasting results, showing association with
longevity in some cases but not in others. It is likely that
positive results were obtained in populations were muta-
tions on complex I were not associated with mutations
on complex III or V, while negative results were ob-
tained in populations with high prevalence of mtDNA
haplotypes carrying mutations on complex I in associ-
ation with mutations in complex III and V. This ap-
proach confirmed that most of the genetic variants have
a very limited effect on longevity, and that only their cu-
mulative effect can give a consistent appreciable effect
and suggests that a limit of previous analyses has been
to search for single mutations instead of cumulative ef-
fects. On the other hand, it is very difficult to think of
using such approach, which has been successful for
mitochondrial DNA, on genomic DNA unless small
fractions (or specific regions harboring genes involved in
relevant pathways) are analyzed.
On the whole, the genetic association studies sug-
gested that, also in humans, mutations in genes corre-
lated with the maintenance of the cell and of its basic
metabolism are essential in modulating lifespan. Indeed,
genes involved in DNA repair [34], telomere conserva-
tion [35–37], heat shock response [38, 39], and the man-
agement of free radicals’ levels [33, 40] were found to
contribute to longevity or, in case of reduced functional-
ity, to accelerated senescence (cellular aging) and the
consequent organism aging. In addition, as suggested by
the studies in mice, the pathways involved in nutrient-
sensing signaling and in regulating transcription, such as
IGF-1/insulin axis [41] and TOR (target of rapamycin)
[42] showed to be involved in modulating human
longevity. Besides these genes involved in cellular main-
tenance/metabolism and senescence, concurrent efforts,
especially from clinical studies, also showed that genes
implicated in important organismal process may have a
strong impact on aging and longevity. For instance genes
involved in lipoprotein metabolism (especially APOE),
cardiovascular homeostasis, immunity, and inflammation
have been found to play an important role in aging, age-
related disorders, and organism longevity [43–46].
Human longevity and life style
Life expectancy at birth has been increasing for most of
the last century in western societies, thanks to the con-
tinuous amelioration of medical assistance, to the im-
provement of the environment (in particular clean, safe
water and food), and to the improvement of nutrients.
For instance, in Italy life expectancy went from 29 years
in 1861 to 82 in 2011 (Table 1 reports the evolution of
this data in women and men). Similarly, the extreme
longevity has been growing in these years. Indeed, the
number of centenarians (still in Italy) remarkably in-
creased from 165 in 1951 to more than 15000 in 2011.
These results have been attained first by a dramatic
reduction of infectious diseases, which, on turn, has dra-
matically reduced infantile mortality, but also mortality
in adult age. In fact, in 2011 less than 10 % of deaths oc-
curred in subjects under 60 years of age, while the corre-
sponding figures were 74 % in 1872, 56 % in 1901 and
25 % in 1951. However, in the last decades, the continu-
ous extension of lifespan was mainly due to the
improvement of medical assistance with respect to age-
related diseases, especially Cardiovascular Diseases and
Cancer, which allowed to increase lifespan of 5 years in
the last 2 decades and of 2 years in the last 10 years
(data from www.mortality.org and www.istat.it).
These data clearly show that environmental factors
have a very strong impact on lifespan and on longevity
in humans. However, the extension of lifespan that there
has been in the last decades have not been accompanied
Table 1 Evolution of lifespan expectancy in Italy from 1861
Year Male Female Total
1861 28 29 29
1871 30 31 30
1881 35 35 35
1891 38 39 38
1901 43 43 43
1911 46 46 46
1921 48 50 49
1931 53 56 55
1941 55 58 56
1951 63 67 65
1961 67 72 69
1971 69 75 72
1981 71 78 75
1991 74 80 77
2001 77 83 80
2011 79 84 82
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by a similar extension of healthy lifespan. Indeed, in
most cases this lifespan extension is due to the chronicit
of the age-related diseases. This has brought the commu-
nity of biogerontologists to study interventions, possibly
modulated on the knowledge emerged from the studies on
the genetic and biomolecular basis of longevity, to extend
not only lifespan but also healthy lifespan, or, with a new
word, “healthspan”. In fact, model organisms with muta-
tions that extend lifespan have a healthy life also when they
are old. This suggested that health span extension could be
attained by targeting (stimulating or silencing) the genes,
which had been highlighted to be involved in life extension
in both model organisms and humans [47]. In support of
this hypothesis, it has been reported that dietary restricted
mice, which live much longer and show a very delayed
aging phenotype than mice fed at libitum, at old age have
an expression pattern very different from mice of the same
age for a number of genes correlated with life extension,
such as those related to DNA repair, stress response, im-
mune response and others [48, 49]. Thus, dietary restriction
can trigger a molecular-genetic response which postpones
aging and age-related phenotypes. This has brought to
search for drugs or interventions which may act on these
mechanisms without the side effects of calorie restriction.
Among the most important interventions which have been
considered in this context, we may name the protein re-
striction, the use of drugs targeting different genes of IGF-1
axis or of the FOXO/TOR pathway [47]. In addition, these
studies have allowed to reconsider previous data on some
areas characterized by exceptional longevity (such as Oki-
nawa, Sardinia and Calabria) which are characterized by
traditional ipoproteic diets, such as the “Mediterranean
diet” [50–53]. In these cases, then, the environment, that is
the traditional diet, has allowed to stimulate the molecular
mechanisms which can increase life span.
Among the several changes that occur with the aging
process, in the last decade Epigenomics has attracted the
interest of many researchers. This was mainly due to the
fact that epigenetic modifications summarizing, at least
in part, the interaction between the individual genetic
background and lifestyle characteristics, should be
potentially able to capture part of the unexplained sus-
ceptibility observed today for complex diseases (the so-
called missing heritability problem).
Starting from the pioneeristic observations that epi-
genetic modifications affect not only the aging process
but also its quality (successful aging) [54], EpiGenome-
Wide Association Studies identified hundreds of sites
spread along the entire genome in which methylation
levels change between oldest old and younger subjects.
In particular, Horwat and co-workers, on the basis of the
methylation levels of 353 CpG units, formulated a math-
ematical model, the so-called epigenetic clock, that
showed some important properties [55]. First, it was able
predict the chronological age of a subject starting from
the methylation level of several cells and tissues of his
body. Second, it represents one of the most accurate bio-
marker of age (also superior to the estimates obtained
from the telomere length). Third, using methylation
levels of blood and brain tissues from subjects affected
by Down syndrome, it showed that an accelerated aging
occur in such a syndrome [56]. Fourth, it was able to
predict all-cause mortality also after adjusting for
traditional risk factors [57]. Finally, when it was used to
estimate the biological age of several tissues from super-
centenarians, it has been demonstrated that brain and
muscle represent the youngest tissues of these excep-
tional individuals [58].
However, even if the cause-effect relationship between
methylation process and aging is still not clear, the
potential applications of this discovery are very wide,
ranging from detailed monitoring of changes occurring
with age within individual systems or organs (muscle,
brain, etc.) to forensic purposes. For this and several
other reasons, future advances in this field could help
the understanding of the complex physiology of aging,
lifespan and age-associated diseases.
Conclusions
On the whole, although the common variability accounts
for only 25 % of human lifespan variability, the know-
ledge of the genetic basis modulating longevity may give
significant hints on modulating lifestyle in order to at-
tain longevity and extend healthspan. That is, a few sub-
jects can attain longevity because a lucky combination of
polymorphisms which allow them to have an efficient
metabolism or an efficient response to different stress.
Most of the others can attain a similar result by target-
ing the same pathways with appropriate life style or in-
terventions. In this context, the importance of epigenetic
factors, both as biomarkers of aging and target of inter-
ventions will certainly grow in the forthcoming future.
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